FDA Adverse Event Malfunction Summary report: N

ALINITY I STAT HIGH SENSITIVE TROPONIN-I REAGENT KIT

MDR report key: 25001026 · Received April 27, 2026

Report

Report Number
3005094123-2026-00192
Event Type
Malfunction
Date Received
April 27, 2026
Date of Event
April 15, 2026
Report Date
April 27, 2026
Manufacturer
ABBOTT IRELAND DIAGNOSTICS DIVISION
Product Code
MMI
UDI-DI
00380740160630
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
EI
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 08P13 THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 04Z21, ALINITY I STAT HIGH SENSITIVITY TROPONIN-I, WITH 510K/PMA/BLA NUMBER K202525. SECTION E: E1 - ADDRESS 1: COMPLETE ADDRESS INFORMATION: DEPARTMENT OF CLINICAL BIOCHEMISTRY AND DIAGNOSTIC ENDOCRINOLOGY AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE.

Description of Event or Problem · 0

A CONFERENCE ABSTRACT BY CULLEN, M.R., AND LEE, G.R., ¿EVALUATION OF FREE THYROXINE AND HIGH SENSITIVITY CARDIAC TROPONIN DUPLICATE TESTING,¿ CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2026; 64(4): EA78. DOI: 10.1515/CCLM-2026-0148, DESCRIBES THE USE OF ROUTINE DUPLICATE TESTING AS A RISK MANAGEMENT STRATEGY TO DETECT ANALYTICAL ERRORS IN ELEVATED ALINITY I STAT HIGH SENSITIVE TROPONIN I RESULTS GENERATED BY THE ALINITY I PROCESSING MODULES. DUPLICATE TESTING WAS PERFORMED FOR ALL ELEVATED ALINITY I STAT HIGH SENSITIVE TROPONIN I RESULTS >7 NG/L. ANALYTICAL ERROR WAS DETECTED IN 112 (B)(4) OF 13,772 DUPLICATE MEASUREMENTS, WITH CRITICAL ERRORS (THOSE CROSSING SEX SPECIFIC (B)(4) PERCENTILE DECISION LIMITS) OCCURRING IN ONLY 5 (0.04%) OF CASES. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
532776 ALINITY I STAT HIGH SENSITIVE TROPONIN-I REAGENT KIT IMMUNOASSAY METHOD, TROPONIN SUBUNIT MMI ABBOTT IRELAND DIAGNOSTICS DIVISION 00380740160630

Patients

Seq Age Sex Outcome Treatment
1